Registration - Organization

MERCK CANADA INC. / Marwan Akar, President and Managing Director

Registration Information

Organization name: MERCK CANADA INC.
Previous Organization names
Senior Officer Name: Marwan Akar, President and Managing Director
Senior Officer Change History
Initial registration start date: 2010-05-07
Registration status: Active
Projected end date: No date provided
Registration number: 8265-2093

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 18

Lobbying Activity Reports - last 6 months: 0

Version 24 of 34 (2020-11-16 to 2021-01-28)

Registration versions:

Version 24 of 34 (2020-11-16 to 2021-01-28)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Communicate with BC government about conditions under which innovative drugs and vaccines are marketed and reimbursed in BC, including under the BC Drug Plans or under federal legislation. In particular, communicating with respect to the integration of biosimilar drugs into the BC Drug Plans and to emphasize the importance that federal and provincial governments respect their respective jurisdiction for approval of marketing and reimbursement of drugs.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Communicate with BC government to leverage BC programs and related resources/tools as a best practice in other markets.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Communicate with BC government to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, biosimilar drugs and vaccines.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Discuss legislation enacted or proposed to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health
Engage BC government on Merck’s commercial product/asset pipeline and seek access listing agreements.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity	Health

BC Ministries/Provincial Entities

Health
Member(s) of the BC Legislative Assembly
Provincial Health Services Authority
University of British Columbia

Organization Details

Senior Officer Name and Position during the Period of this Registration

Anna Van Acker, President and Managing Director

Organization Contact Information

MERCK CANADA INC.

Address:
16750 TransCanada Highway
Kirkland, BC H9H 4M7
Canada

Telephone number: 604-643-7996
Fax number: 604-643-7900

Description of Activities

For over a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Coalition Members Information

BIOTECanada
- 1 Nicholas Street
  Suite 600
  Ottawa, ON K1N 7B7
  Canada
Canadian Biosimilars Forum
- PO Box 47099
  Dundas Square PO
  Toronto, ON M5B 2G0
  Canada
Innovative Medicines Canada
- Suite 1220
  55 Metcalfe Street
  Ottawa, ON K1P 6L5
  Canada

Affiliates with a Direct Interest in the Outcome

Merck & Co.
- 1959 Upper Water Street
  Suite 900
  Halifax, NS B3J 2X2
  Canada

Other Persons or Organizations with Direct Interests

The activities of MERCK CANADA INC. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Jennifer Chan
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No